These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6893824)
1. Monopyrroles in porphyria, psychosis and lead exposure. Moore MR; Graham DJ Int J Biochem; 1980; 12(5-6):827-32. PubMed ID: 6893824 [No Abstract] [Full Text] [Related]
2. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458 [No Abstract] [Full Text] [Related]
3. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Blum I; Schoenfeld N; Atsmon A Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745 [No Abstract] [Full Text] [Related]
4. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria. Kappas A; Sassa S; Granick S; Bradlow HL Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660 [No Abstract] [Full Text] [Related]
5. Hemes, chlorophylls, and related compounds: biosynthesis and metabolic regulation. Granick S; Beale SI Adv Enzymol Relat Areas Mol Biol; 1978; 46():33-203. PubMed ID: 345768 [No Abstract] [Full Text] [Related]
6. Defects in haem synthesis in mammalian tissues in experimental lead poisoning and experimental porphyria. Gibson SL; Goldberg A Clin Sci; 1970 Jan; 38(1):63-72. PubMed ID: 5411483 [No Abstract] [Full Text] [Related]
7. [Intermittent acute porphyria. Hepatic ultrastructural study]. Gaultier M; Gervais P; Bescol J; Conso F; Aubry P; Guillam C Ann Med Interne (Paris); 1974; 125(6-7):539-46. PubMed ID: 4440969 [No Abstract] [Full Text] [Related]
8. The laboratory investigation of the porphyrin disorders: a review. Sinnott JL Med Lab Sci; 1976 Apr; 33(2):133-53. PubMed ID: 781455 [No Abstract] [Full Text] [Related]
9. Intermittent acute porphyria: the enzymatic defect. Meyer UA; Schmid R Res Publ Assoc Res Nerv Ment Dis; 1974; 53():211-24. PubMed ID: 4280105 [No Abstract] [Full Text] [Related]
10. The effects of selected monopyrroles on various aspects of heme biosynthesis and degradation in the rat. Graham DJ; Thompson GG; Moore MR; Goldberg A Arch Biochem Biophys; 1979 Oct; 197(1):132-8. PubMed ID: 583487 [No Abstract] [Full Text] [Related]
11. Hepatic porphyrias: new findings on the nature of metabolic defects. Meyer UA Prog Liver Dis; 1976; 5():280-93. PubMed ID: 775544 [No Abstract] [Full Text] [Related]
12. Drugs and porphyria. De Matteis F S Afr Med J; 1971 Sep; ():126-33. PubMed ID: 5150265 [No Abstract] [Full Text] [Related]
13. Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria. Schuurmans MM; Hoffmann F; Lindberg RL; Meyer UA Hepatology; 2001 May; 33(5):1217-22. PubMed ID: 11343251 [TBL] [Abstract][Full Text] [Related]
18. Porphyrin biosynthesis. Enhancement of the fractional catabolic rate of microsomal haem in chemically induced porphyria. Meyer UA; Marver HS S Afr Med J; 1971 Sep; ():175-7. PubMed ID: 5150273 [No Abstract] [Full Text] [Related]
19. Lead poisoning as a disorder of heme synthesis. Goldberg A Semin Hematol; 1968 Oct; 5(4):424-33. PubMed ID: 5742911 [No Abstract] [Full Text] [Related]
20. Treatment of the porphyrias: mechanisms of action. Bickers DR J Invest Dermatol; 1981 Jul; 77(1):107-13. PubMed ID: 7252241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]